analyst
RA
NASDAQ · RARE
Ultragenyx Pharmaceutical Inc.
Healthcare · Biotechnology
$16.14
Up+$0.27 (+1.65%)
Updated Nov 11, 2026, 3:42 PM
SID Score
4.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.49B
- P/E ratio
- -6.23
- Dividend yield
- 0.00%
- 52-week range
- $12.73 – $39.89
- Volume
- 5.46M
- Avg. volume
- 1.5M
Price performance · RARE
RARE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 10, 2026
RARE closed at $16.14 after 21 trading sessions, up 8.18% for the selected period.
- Last close
- $16.14
- Period change
- +8.18%
- Period low
- $14.54
- Period high
- $17.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | $16.17 | $16.35 | $15.455 | $16.14 | 5.46M |
| Nov 9, 2026 | $15.745 | $16.51 | $15.3163 | $16.41 | 2.67M |
| Nov 6, 2026 | $15.675 | $15.9675 | $15.12 | $15.43 | 4.05M |
| Nov 5, 2026 | $17.07 | $17.12 | $15.4923 | $15.57 | 5.39M |
| Nov 4, 2026 | $17.04 | $17.67 | $16.23 | $17.16 | 7.51M |
| Nov 3, 2026 | $16.52 | $16.99 | $16.38 | $16.63 | 3.71M |
| Nov 2, 2026 | $16.29 | $16.44 | $15.85 | $16.30 | 4.84M |
| Oct 30, 2026 | $16.64 | $16.9299 | $15.92 | $16.10 | 2.33M |
| Oct 29, 2026 | $17.26 | $17.625 | $16.71 | $16.78 | 2.8M |
| Oct 28, 2026 | $16.73 | $17.3499 | $16.4734 | $17.20 | 2.32M |
| Oct 27, 2026 | $16.05 | $16.96 | $15.88 | $16.75 | 4.94M |
| Oct 26, 2026 | $15.75 | $16.22 | $15.59 | $16.08 | 3.02M |
| Oct 23, 2026 | $15.92 | $15.94 | $15.49 | $15.65 | 1.79M |
| Oct 22, 2026 | $15.78 | $16.25 | $15.60 | $15.95 | 2.37M |
| Oct 21, 2026 | $16.02 | $16.31 | $15.785 | $15.92 | 2.83M |
| Oct 20, 2026 | $15.01 | $16.27 | $14.99 | $16.02 | 3.55M |
| Oct 19, 2026 | $14.67 | $15.08 | $14.535 | $15.07 | 2.98M |
| Oct 16, 2026 | $15.11 | $15.21 | $14.44 | $14.54 | 2.93M |
| Oct 15, 2026 | $14.87 | $15.37 | $14.79 | $15.17 | 3.33M |
| Oct 14, 2026 | $14.93 | $15.18 | $14.67 | $14.90 | 2.96M |
| Oct 13, 2026 | $15.27 | $15.39 | $14.69 | $14.92 | 5.31M |
Latest RARE news
The latest Smart Investors Daily articles mentioning RARE.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

